Cargando…
Nitroxide pharmaceutical development for age-related degeneration and disease
Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular degeneration (AMD) and cardiovascular disease, which are two major diseases of aging. These aging diseases are associated with patient genetics, smoking, diet, oxidative str...
Autores principales: | Zarling, Jacob A., Brunt, Vienna E., Vallerga, Anne K., Li, Weixing, Tao, Albert, Zarling, David A., Minson, Christopher T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635221/ https://www.ncbi.nlm.nih.gov/pubmed/26594225 http://dx.doi.org/10.3389/fgene.2015.00325 |
Ejemplares similares
-
Can targeting glutamate receptors with long-term heat acclimation improve outcomes following hypoxic injury?
por: Ely, Brett R, et al.
Publicado: (2015) -
Acceptance Commitment Therapy Intervention for Custodial Grandfamilies
por: Faulhaber, Manuela E, et al.
Publicado: (2020) -
The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age
por: Schick, Tina, et al.
Publicado: (2020) -
Memory CD8 T Cells Specific for Plasmodia Liver-Stage Antigens Maintain Protracted Protection Against Malaria
por: Krzych, Urszula, et al.
Publicado: (2012) -
Therapist use of cognitive behavior therapy and eye movement desensitization and reprocessing components for the treatment of posttraumatic stress disorder in practice settings
por: Neill, Erin L., et al.
Publicado: (2023)